PMCPA Case
| Case | AUTH/3799/7/23 |
| Company | Grünenthal |
| Type | Voluntary admission |
| Issue | Failure to take the appropriate ABPI Examination within the first year of employment as a representative |
| Employee area | Market Access (role entailed calling upon health professionals) |
| Applicable Code year | 2021 |
| Breach clauses | Clause 9.4 |
| Complaint received | 14 July 2023 |
| Case completed | 12 August 2024 |
| Appeal | No appeal |
| Sanctions | Undertaking received; additional sanctions: Not stated |
| Key dates mentioned | Employment start: February 2022; first module: 23 April 2023; should have taken modules by: 21 February 2023; passed within two years by: 21 February 2024 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.